about
Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac DeathThe Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative ReviewFrom C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionLooking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium SurvivalNeutrophil elastase promotes interleukin-1β secretion from human coronary endothelium.Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy.Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinraRelative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarctionIndependent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.The inflammatory response in myocardial injury, repair, and remodelling.Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.Role of Interleukin-1 in Radiation-Induced Cardiomyopathy.Clinical predictors of response to anakinra in patients with heart failure.Preventing Heart Failure in Inflammatory and Immune DisordersCytokines: roles in atherosclerosis disease progression and potential therapeutic targetsTargeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial InfarctionIL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1βRole of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.An observational study of the association among interatrial adiposity by computed tomography measure, insulin resistance, and left atrial electromechanical disturbances in heart failureInterleukin-1β gene variants are associated with QTc interval prolongation following cardiac surgery: a prospective observational study.Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.Ten-year alcohol consumption typologies and trajectories of C-reactive protein, interleukin-6 and interleukin-1 receptor antagonist over the following 12 years: a prospective cohort study.Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function.A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse.The effect of anakinra on retinal function in isolated perfused vertebrate retina.Targeting interleukin-1 in heart failure and inflammatory heart disease.Inflammatory markers in ST-elevation acute myocardial infarction.Targeting danger-associated molecular patterns after myocardial infarction.L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages.Interleukin-1 Blockade for the Treatment of Pericarditis.Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production.Evaluation of Innate Immunity Biomarkers on Admission and at Discharge From an Acute Heart Failure Episode.Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation.NOD1, a new player in cardiac function and calcium handling.Vinexin-β exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses.The IL-1RI Co-Receptor TILRR (FREM1 Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease.Inflammatory activation of human cardiac fibroblasts leads to altered calcium signaling, decreased connexin 43 expression and increased glutamate secretion
P2860
Q26744359-649A3420-F5DC-48F6-8F5F-90E212059541Q26768281-8D03AF43-D8E4-46D1-8BBE-B3008AFD2558Q26770209-2C684526-A0C3-46C7-B8C5-EB928B2D84BFQ26778539-2A976376-360E-4C8A-A542-B2EE8C047CCDQ27312465-2DA0B054-C91A-4A67-9580-ED94D9592A5EQ33648781-45640C67-455E-473B-A503-04D8B223F534Q33801215-C394DA11-B0AC-4D64-B887-0FD952A73174Q34777497-A46A1275-3326-4B41-9005-414B510F6A65Q35070840-5F6207FE-19D2-4376-A22C-F978DA2A98B3Q35171781-771F3F83-ED6B-47B6-901F-84CB7299B0BAQ35529656-0FA4B02C-9F1B-4A9A-8C45-62B323F9DF58Q35847003-71FDD7D9-5FB6-4399-8A7E-199A301D4EC2Q35855691-04F39BCB-DCC4-4E56-867E-FC9B7CC46F29Q35898868-C83F69F8-AE35-4E10-906E-FC00A866D28FQ35994802-6C0BB163-777E-4B25-B847-8BFE2121D1C2Q36064353-B642D97A-AB71-4FF5-A0E9-3FEB8F39D323Q36296699-96377EB0-219E-43CC-B43B-B55F0CB7F5E6Q36326783-CDB8B3B2-D413-4FCA-B6D6-E90C28D47786Q36849601-55BC67EC-4CB7-4DA0-8557-9B161B51635EQ37205740-56CA8388-20AB-4995-805E-C3D8A1D1DED2Q37306897-A57BE2A7-952A-4E42-94B8-B28B4567D117Q37308677-C400B41F-DFC0-421B-92FB-3218BD3DE36BQ37361075-F1F3CE5C-363F-4858-BD19-CF815D36D3BBQ37520958-5A4606EE-EC46-409F-9F92-711CBCE67419Q37656103-92A6F62A-C71C-4924-8A55-D517EEF31BFDQ37680021-0B9BC806-B479-4DFB-9BCE-15CA7520D85AQ37692892-F7A960F7-8E83-4D21-AB94-47ED6BECE945Q37716334-A55562F7-0D33-4AC9-89E9-C7D83A0A2500Q38260179-0F6EEE81-D00C-4D52-B5AB-CCB71ADC1AA9Q38355385-C755AD30-270D-4789-B38F-C9F8DC55B300Q38595544-9F709AB1-8A31-4FF5-A3C2-13EC28389F5AQ38730205-C2E244F4-D39C-4AC8-9169-EEA662BA94DEQ39386445-4C80FB94-96DB-45BD-A002-5AC7C8BEA25BQ40479886-D28FD126-B5A7-4DAA-81C9-0E4E80893B15Q40481029-CBCE2249-02DC-4C77-9B78-F29046CAEB2AQ41072992-540E79FF-81AF-465B-B6C6-C0970C20C3FBQ41138874-D34640B0-4718-4246-B915-6A7563C83864Q41469937-5259BC12-99E1-4F49-A5D5-157421697BF8Q41599612-E51D8AAC-C2F9-4FA1-B515-40EE9488CEABQ42210513-2D42B7E1-E785-4058-AF5C-557AACC71321
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeting interleukin-1 in heart disease
@ast
Targeting interleukin-1 in heart disease
@en
Targeting interleukin-1 in heart disease
@nl
type
label
Targeting interleukin-1 in heart disease
@ast
Targeting interleukin-1 in heart disease
@en
Targeting interleukin-1 in heart disease
@nl
prefLabel
Targeting interleukin-1 in heart disease
@ast
Targeting interleukin-1 in heart disease
@en
Targeting interleukin-1 in heart disease
@nl
P2093
P2860
P3181
P1433
P1476
Targeting interleukin-1 in heart disease
@en
P2093
B. W. Van Tassell
E. Mezzaroma
P2860
P304
P3181
P356
10.1161/CIRCULATIONAHA.113.003199
P407
P577
2013-10-22T00:00:00Z